Approval · Notice of Compliance 8667 · 2007
ZOFRAN: Notice of Compliance 8667
Issued March 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8667
- Date
- March 23, 2007
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the clinical trials section and other revisions to the product monograph
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOFRAN | Not yet assigned | — |
| ZOFRAN ODT | Not yet assigned | — |
Medicinal ingredients
- ONDANSETRON HYDROCHLORIDE DIHYDRATE 4 MG per TAB
- ONDANSETRON HYDROCHLORIDE DIHYDRATE 8 MG per TAB
- ONDANSETRON HYDROCHLORIDE DIHYDRATE 4 MG per 5ML
- ONDANSETRON HYDROCHLORIDE DIHYDRATE 2 MG per ML
- ONDANSETRON 4 MG per TAB
- ONDANSETRON 8 MG per TAB